Literature DB >> 1827417

Seizures in children with Down syndrome: etiology, characteristics and outcome.

C E Stafstrom1, O F Patxot, H E Gilmore, K E Wisniewski.   

Abstract

Of 737 patients with Down syndrome, newborn to 22 years of age, 47 had a history of at least one seizure. Of those, 24 children had seizures with an identifiable etiology, usually related to a common medical complication of Down syndrome: neonatal hypoxia-ischemia, hypoxia from congenital heart disease, or infection. These acute medical illnesses may precipitate seizures in brains already predisposed to hyperexcitability because of abnormal neuronal development. It is recommended that all Down syndrome children with seizures undergo investigations to determine the etiology of the seizure.

Entities:  

Mesh:

Year:  1991        PMID: 1827417     DOI: 10.1111/j.1469-8749.1991.tb05108.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  10 in total

Review 1.  Clinical review of genetic epileptic encephalopathies.

Authors:  Grace J Noh; Y Jane Tavyev Asher; John M Graham
Journal:  Eur J Med Genet       Date:  2012-01-25       Impact factor: 2.708

2.  Long-term outcome of epilepsy in patients with Prader-Willi syndrome.

Authors:  Alberto Verrotti; Raffaella Cusmai; Daniela Laino; Marco Carotenuto; Maria Esposito; Raffaele Falsaperla; Lucia Margari; Renata Rizzo; Salvatore Savasta; Salvatore Grosso; Pasquale Striano; Vincenzo Belcastro; Emilio Franzoni; Paolo Curatolo; Lucio Giordano; Elena Freri; Sara Matricardi; Dario Pruna; Irene Toldo; Elisabetta Tozzi; Lucio Lobefalo; Francesca Operto; Emma Altobelli; Francesco Chiarelli; Alberto Spalice
Journal:  J Neurol       Date:  2014-10-18       Impact factor: 4.849

3.  A Retrospective Cohort Study of Combined Therapy in West Syndrome associated with Trisomy 21.

Authors:  Luciana de Paula Souza; Beatriz Bagatin Bermudez; Danielle Caldas Bufara; Ana Chrystina de Souza Crippa
Journal:  Child Neurol Open       Date:  2022-10-13

Review 4.  Epilepsy and chromosomal abnormalities.

Authors:  Giovanni Sorge; Anna Sorge
Journal:  Ital J Pediatr       Date:  2010-05-03       Impact factor: 2.638

5.  The HSA21 gene EURL/C21ORF91 controls neurogenesis within the cerebral cortex and is implicated in the pathogenesis of Down Syndrome.

Authors:  Shan Shan Li; Zhengdong Qu; Matilda Haas; Linh Ngo; You Jeong Heo; Hyo Jung Kang; Joanne Maria Britto; Hayley Daniella Cullen; Hannah Kate Vanyai; Seong-Seng Tan; Tailoi Chan-Ling; Jenny Margaret Gunnersen; Julian Ik-Tsen Heng
Journal:  Sci Rep       Date:  2016-07-11       Impact factor: 4.379

6.  Acute Regression in Young People with Down Syndrome.

Authors:  Clotilde Mircher; Cécile Cieuta-Walti; Isabelle Marey; Anne-Sophie Rebillat; Laura Cretu; Eliane Milenko; Martine Conte; Franck Sturtz; Marie-Odile Rethore; Aimé Ravel
Journal:  Brain Sci       Date:  2017-05-27

Review 7.  The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome.

Authors:  Andrea Contestabile; Salvatore Magara; Laura Cancedda
Journal:  Front Cell Neurosci       Date:  2017-03-07       Impact factor: 5.505

8.  Treatment of Epilepsy Associated with Common Chromosomal Developmental Diseases.

Authors:  Magdalena Budisteanu; Claudia Jurca; Sorina Mihaela Papuc; Ina Focsa; Dan Riga; Sorin Riga; Alexandru Jurca; Aurora Arghir
Journal:  Open Life Sci       Date:  2020-02-28       Impact factor: 0.938

9.  Adult-onset fluoxetine treatment does not improve behavioral impairments and may have adverse effects on the Ts65Dn mouse model of Down syndrome.

Authors:  Markus Heinen; Moritz M Hettich; Devon P Ryan; Susanne Schnell; Katharina Paesler; Dan Ehninger
Journal:  Neural Plast       Date:  2012-07-16       Impact factor: 3.599

Review 10.  Down syndrome and type I interferon: not so simple.

Authors:  Louise Malle; Dusan Bogunovic
Journal:  Curr Opin Immunol       Date:  2021-06-23       Impact factor: 7.268

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.